{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:47:19Z","timestamp":1786981639513,"version":"build-2736575974"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T00:00:00Z","timestamp":1704412800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T00:00:00Z","timestamp":1704412800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["61905280"],"award-info":[{"award-number":["61905280"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82104303"],"award-info":[{"award-number":["82104303"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"DOI":"10.1007\/s11239-023-02919-2","type":"journal-article","created":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T07:02:12Z","timestamp":1704438132000},"page":"194-203","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Short-term antiplatelet versus anticoagulant therapy after left atrial appendage closure: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"57","author":[{"given":"Qiang","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Chun","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-hui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-zi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-ying","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,5]]},"reference":[{"issue":"5","key":"2919_CR1","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"G Hindricks","year":"2021","unstructured":"Hindricks G, Potpara T, Dagres N et al (2021) 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 42(5):373\u2013498","journal-title":"Eur Heart J"},{"issue":"7","key":"2919_CR2","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.amjmed.2009.11.025","volume":"123","author":"IM Ogilvie","year":"2010","unstructured":"Ogilvie IM, Newton N, Welner Sharon A et al (2010) Underuse of oral anticoagulants in atrial fibrillation: a systematic review. Am J Med 123(7):638\u2013645","journal-title":"Am J Med"},{"issue":"2","key":"2919_CR3","first-page":"199","volume":"7","author":"B Kong","year":"2015","unstructured":"Kong B, Liu Y, Huang H et al (2015) Left atrial appendage closure for thromboembolism prevention in patients with atrial fibrillation: advances and perspectives. J Thorac Dis 7(2):199\u2013203","journal-title":"J Thorac Dis"},{"issue":"2","key":"2919_CR4","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1161\/CIR.0000000000000665","volume":"140","author":"CT January","year":"2019","unstructured":"January CT, Wann LS, Calkins H et al (2019) 2019 AHA\/ACC\/HRS focused update of the 2014 AHA\/ACC\/HRS Guideline for the management of patients with Atrial Fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice guidelines and the heart rhythm society in collaboration with the Society of thoracic surgeons. Circulation 140(2):e125\u2013151","journal-title":"Circulation"},{"issue":"1","key":"2919_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2021.10.023","volume":"79","author":"P Osmancik","year":"2022","unstructured":"Osmancik P, Herman D, Neuzil P et al (2022) 4-Year outcomes after left atrial appendage Closure Versus nonwarfarin oral anticoagulation for Atrial Fibrillation. J Am Coll Cardiol 79(1):1\u201314","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"2919_CR6","first-page":"e010195","volume":"14","author":"A Sedaghat","year":"2021","unstructured":"Sedaghat A, Vij V, Al-Kassou B et al (2021) Device-related thrombus after left atrial appendage closure: data on thrombus characteristics, treatment strategies, and clinical outcomes from the EUROC-DRT-Registry. Circulation 14(5):e010195","journal-title":"Circulation"},{"issue":"12","key":"2919_CR7","first-page":"937","volume":"47","author":"Chinese society of cardiology of Chinese medical association, editorial board of Chinese journal of cardiology","year":"2019","unstructured":"Chinese society of cardiology of Chinese medical association, editorial board of Chinese journal of cardiology (2019) 2019 Chinese Society of Cardiology (CSC) expert consensus statement on left atrial appendage closure in the prevention of Stroke in patients with atrial fibrillation. Zhonghua Xin xue guan bing za zhi 47(12):937\u2013955","journal-title":"Zhonghua Xin xue guan bing za zhi"},{"issue":"2","key":"2919_CR8","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1253\/circj.CJ-21-0162","volume":"86","author":"A Nogami","year":"2022","unstructured":"Nogami A, Kurita T, Kusano K et al (2022) JCS\/JHRS 2021 Guideline focused update on Non-pharmacotherapy of Cardiac Arrhythmias. Circ J 86(2):337\u2013363","journal-title":"Circ J"},{"key":"2919_CR9","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ijcard.2021.02.054","volume":"333","author":"L Faroux","year":"2021","unstructured":"Faroux L, Cruz-Gonz\u00e1lez I, Arzamendi D et al (2021) Short-term direct oral anticoagulation or dual antiplatelet therapy following left atrial appendage closure in patients with relative contraindications to chronic anticoagulation therapy. Int J Cardiol 333:77\u201382","journal-title":"Int J Cardiol"},{"issue":"11","key":"2919_CR10","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.jcin.2019.04.004","volume":"12","author":"L S\u00f8ndergaard","year":"2019","unstructured":"S\u00f8ndergaard L, Wong YH, Reddy VY et al (2019) Propensity-matched comparison of oral anticoagulation versus antiplatelet therapy after left atrial appendage closure With WATCHMAN. JACC Cardiovasc Interv 12(11):1055\u20131063","journal-title":"JACC Cardiovasc Interv"},{"key":"2919_CR11","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jclinepi.2009.06.006","volume":"62","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 62:e1\u201334","journal-title":"J Clin Epidemiol"},{"key":"2919_CR12","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JP Higgins","year":"2011","unstructured":"Higgins JP, Altman DG, G\u00f8tzsche PC et al (2011) The Cochrane collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ 343:d5928","journal-title":"BMJ"},{"key":"2919_CR13","unstructured":"Wells G, Shea B, O\u2019Connell D et al The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses [Online]. Ottawa Hospital Research Institute Research Programs. Available at\u00a0http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp"},{"issue":"5","key":"2919_CR14","doi-asserted-by":"crossref","first-page":"e2214594","DOI":"10.1001\/jamanetworkopen.2022.14594","volume":"5","author":"F Su","year":"2022","unstructured":"Su F, Gao C, Liu J et al (2022) Periprocedural outcomes Associated with Use of a left atrial appendage occlusion device in China. JAMA Netw Open 5(5):e2214594","journal-title":"JAMA Netw Open"},{"issue":"18","key":"2919_CR15","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.jacc.2022.02.047","volume":"79","author":"JV Freeman","year":"2022","unstructured":"Freeman JV, Higgins AY, Wang Y et al (2022) Antithrombotic therapy after left atrial appendage occlusion in patients with Atrial Fibrillation. J Am Coll Cardiol 79(18):1785\u20131798","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"2919_CR16","first-page":"489","volume":"64","author":"J Ledwoch","year":"2022","unstructured":"Ledwoch J, Staubach S, Akin I et al (2022) Anticoagulation versus antiplatelet therapy after percutaneous left atrial appendage closure-subanalysis from the multicenter LAARGE registry. J\u00a0Interv\u00a0Card\u00a0Electrophysiol 64(2):489\u2013496","journal-title":"J\u00a0Interv\u00a0Card\u00a0Electrophysiol"},{"issue":"9","key":"2919_CR17","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.3390\/jcm10091959","volume":"10","author":"P Mazzone","year":"2021","unstructured":"Mazzone P, Laricchia A, D\u2019Angelo G et al (2021) Role of Different Antithrombotic Regimens after Percutaneous Left Atrial Appendage Occlusion: A Large Single Center Experience. J Clin Med 10(9):1959","journal-title":"J Clin Med"},{"issue":"11","key":"2919_CR18","first-page":"142","volume":"8","author":"PL Cepas-Guillen","year":"2021","unstructured":"Cepas-Guillen PL, Flores-Umanzor E, Regueiro A et al (2021) Low Dose of Direct Oral Anticoagulants after Left Atrial Appendage Occlusion. J Cardiovasc Dev Dis 8(11):142","journal-title":"J Cardiovasc Dev Dis"},{"issue":"7","key":"2919_CR19","first-page":"e008481","volume":"13","author":"G Duthoit","year":"2020","unstructured":"Duthoit G, Silvain J, Marijon E et al (2020) Reduced rivaroxaban dose versus dual antiplatelet therapy after left atrial appendage closure: ADRIFT a randomized pilot study. Circulation 13(7):e008481","journal-title":"Circulation"},{"issue":"8","key":"2919_CR20","first-page":"e009039","volume":"13","author":"L Asmarats","year":"2020","unstructured":"Asmarats L, O\u2019Hara G, Champagne J et al (2020) Short-term oral anticoagulation versus antiplatelet therapy following transcatheter left atrial appendage closure. Circulation 13(8):e009039","journal-title":"Circulation"},{"issue":"7","key":"2919_CR21","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1093\/europace\/euaa074","volume":"22","author":"J Ledwoch","year":"2020","unstructured":"Ledwoch J, Sievert K, Boersma LVA et al (2020) Initial and long-term antithrombotic therapy after left atrial appendage closure with the WATCHMAN. Europace 22(7):1036\u20131043","journal-title":"Europace"},{"issue":"11","key":"2919_CR22","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1111\/pace.14032","volume":"43","author":"XX Liu","year":"2020","unstructured":"Liu XX, Kleinecke C, Busch S et al (2020) Propensity-matched comparison of antiplatelet versus anticoagulant after left atrial appendage closure with the Watchman. Pace 43(11):1242\u20131251","journal-title":"Pace"},{"issue":"7","key":"2919_CR23","doi-asserted-by":"crossref","first-page":"877","DOI":"10.4244\/EIJ-D-17-00042","volume":"13","author":"MW Bergmann","year":"2017","unstructured":"Bergmann MW, Betts TR, Sievert H et al (2017) Safety and efficacy of early anticoagulation drug regimens after WATCHMAN left atrial appendage closure: three-month data from the EWOLUTION prospective, multicentre, monitored international WATCHMAN LAA closure registry. Eurointervention 13(7):877\u2013884","journal-title":"Eurointervention"},{"issue":"5","key":"2919_CR24","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.hlc.2016.09.009","volume":"26","author":"MK Tung","year":"2017","unstructured":"Tung MK, Ramkumar S, Cameron JD et al (2017) Retrospective cohort study examining reduced intensity and duration of anticoagulant and antiplatelet therapy following left atrial appendage occlusion with the WATCHMAN device. Heart Lung circ 26(5):477\u2013485","journal-title":"Heart Lung circ"},{"issue":"12","key":"2919_CR25","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/clc.22478","volume":"38","author":"LI B\u00f6sche","year":"2015","unstructured":"B\u00f6sche LI, Afshari F, Sch\u00f6ne D et al (2015) Initial experience with novel oral anticoagulants during the First 45 days after left atrial appendage Closure with the Watchman device. Clin Cardiol 38(12):720\u2013724","journal-title":"Clin Cardiol"},{"issue":"15","key":"2919_CR26","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/j.jcin.2015.07.040","volume":"8","author":"J Wiebe","year":"2015","unstructured":"Wiebe J, Franke J, Lehn K et al (2015) Percutaneous left atrial appendage closure with the watchman device: long-term results up to 5 years. JACC Cardiovasc Interv 8(15):1915\u20131921","journal-title":"JACC Cardiovasc Interv"},{"issue":"11","key":"2919_CR27","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.jcin.2018.11.001","volume":"12","author":"J Saw","year":"2019","unstructured":"Saw J, Nielsen-Kudsk JE, Bergmann M et al (2019) Antithrombotic therapy and device-related thrombosis following endovascular left atrial appendage closure. JACC Cardiovasc Interv 12(11):1067\u20131076","journal-title":"JACC Cardiovasc Interv"},{"issue":"1","key":"2919_CR28","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.amjcard.2017.03.253","volume":"120","author":"J Rod\u00e9s-Cabau","year":"2017","unstructured":"Rod\u00e9s-Cabau J, O\u2019Hara G, Paradis JM et al (2017) Changes in coagulation and platelet activation markers following transcatheter left Atrial Appendage Closure. Am J Cardiol 120(1):87\u201391","journal-title":"Am J Cardiol"},{"issue":"8","key":"2919_CR29","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.jcin.2010.04.017","volume":"3","author":"RS Schwartz","year":"2010","unstructured":"Schwartz RS, Holmes DR, Van Tassel RA et al (2010) Left atrial appendage obliteration: mechanisms of healing and intracardiac integration. JACC Cardiovasc\u00a0Interv 3(8):870\u2013877","journal-title":"JACC Cardiovasc\u00a0Interv"},{"issue":"14","key":"2919_CR30","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1016\/j.jacc.2018.01.076","volume":"71","author":"L Fauchier","year":"2018","unstructured":"Fauchier L, Cinaud A, Brigadeau F et al (2018) Device-related Thrombosis after percutaneous left atrial appendage occlusion for Atrial Fibrillation. J Am Coll Cardiol 71(14):1528\u20131536","journal-title":"J Am Coll Cardiol"},{"issue":"9689","key":"2919_CR31","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0140-6736(09)61343-X","volume":"374","author":"DR Holmes","year":"2009","unstructured":"Holmes DR, Reddy VY, Turi ZG et al (2009) Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of Stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet 374(9689):534\u2013542","journal-title":"Lancet"},{"issue":"5","key":"2919_CR32","first-page":"e012812","volume":"16","author":"J Mesnier","year":"2023","unstructured":"Mesnier J, Cepas-Guill\u00e9n P, Freixa X et al (2023) Antithrombotic management after left atrial appendage closure: current evidence and future perspectives. Circulation 16(5):e012812","journal-title":"Circulation"},{"issue":"11","key":"2919_CR33","doi-asserted-by":"crossref","first-page":"300060520966478","DOI":"10.1177\/0300060520966478","volume":"48","author":"SY Li","year":"2020","unstructured":"Li SY, Wang J, Hui X et al (2020) Meta-analysis of postoperative antithrombotic therapy after left atrial appendage occlusion. J Int Med Res 48(11):300060520966478","journal-title":"J Int Med Res"},{"issue":"5","key":"2919_CR34","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.jacep.2019.11.009","volume":"6","author":"M Osman","year":"2020","unstructured":"Osman M, Busu T, Osman K et al (2020) Short-term antiplatelet versus anticoagulant therapy after left atrial appendage occlusion: a systematic review and meta-analysis. Clin Electrophysiol 6(5):494\u2013506","journal-title":"Clin Electrophysiol"},{"key":"2919_CR35","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.amjcard.2021.05.010","volume":"153","author":"RM Prasad","year":"2021","unstructured":"Prasad RM, Al-Abcha A, Radwan Y et al (2021) Meta-analysis comparing antiplatelet therapy Versus Direct oral anticoagulation in Percutaneous Left Atrial Appendage Closure. Am J Cardiol 153:144\u2013146","journal-title":"Am J Cardiol"},{"issue":"3","key":"2919_CR36","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0049-3848(02)00023-3","volume":"105","author":"P Peternel","year":"2002","unstructured":"Peternel P, Terbizan M, Tratar G et al (2002) Markers of hemostatic system activation during treatment of deep vein Thrombosis with subcutaneous unfractionated or low-molecular weight heparin. Thromb Res 105(3):241\u2013246","journal-title":"Thromb Res"},{"issue":"1","key":"2919_CR37","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s11239-021-02602-4","volume":"55","author":"A Amirtabar","year":"2023","unstructured":"Amirtabar A, Vazquez SR, Saunders J et al (2023) Antiplatelet therapy indication in patients also prescribed direct oral anticoagulants. J Thromb Thrombolys 55(1):185\u2013188","journal-title":"J Thromb Thrombolys"},{"issue":"6","key":"2919_CR38","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1161\/CIRCULATIONAHA.120.050438","volume":"143","author":"DJ Angiolillo","year":"2021","unstructured":"Angiolillo DJ, Bhatt DL, Cannon CP et al (2021) Antithrombotic therapy in patients with atrial fibrillation treated with oral anticoagulation undergoing percutaneous coronary intervention: a north American perspective: 2021 update. Circulation 143(6):583\u2013596","journal-title":"Circulation"},{"issue":"3","key":"2919_CR39","first-page":"1","volume":"105","author":"H Ge","year":"2022","unstructured":"Ge H, Zhang C, Qiao ZQ et al (2022) Risk of device-related Thrombosis following short-term oral anticoagulation with low-dose dabigatran versus warfarin after Watchman left atrial appendage occlusion. Sci Prog 105(3):1\u201314","journal-title":"Sci Prog"},{"key":"2919_CR40","doi-asserted-by":"crossref","first-page":"614762","DOI":"10.3389\/fphar.2021.614762","volume":"12","author":"X Li","year":"2021","unstructured":"Li X, Zhang X, Jin Q et al (2021) Clinical efficacy and safety comparison of Rivaroxaban and Dabigatran for Nonvalvular Atrial Fibrillation patients undergoing Percutaneous Left Atrial Appendage Closure Operation. Front Pharmacol 12:614762","journal-title":"Front Pharmacol"},{"issue":"21","key":"2919_CR41","first-page":"2353","volume":"14","author":"DG Della Rocca","year":"2021","unstructured":"Della Rocca DG, Magnocavallo M, Di Biase L et al (2021) Half-dose direct oral anticoagulation versus standard antithrombotic therapy after left atrial appendage occlusion. Cardiovasc Interv 14(21):2353\u20132364","journal-title":"Cardiovasc Interv"},{"issue":"12","key":"2919_CR42","first-page":"1533","volume":"7","author":"DG Della Rocca","year":"2021","unstructured":"Della Rocca DG, Horton RP, Di Biase L et al (2021) Incidence of device-related thrombosis in watchman patients undergoing a genotype-guided antithrombotic strategy. Clin\u00a0Electrophysiol 7(12):1533\u20131543","journal-title":"Clin\u00a0Electrophysiol"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-023-02919-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-023-02919-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-023-02919-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T09:03:49Z","timestamp":1730970229000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11239-023-02919-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,5]]},"references-count":42,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,2]]}},"alternative-id":["2919"],"URL":"https:\/\/doi.org\/10.1007\/s11239-023-02919-2","relation":{},"ISSN":["1573-742X"],"issn-type":[{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,5]]},"assertion":[{"value":"30 October 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors report no conflict of interests in this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}